5 Pharmaceutical Stocks to Buy According to Efrem Kamen’s Pura Vida Investments

Page 1 of 5

Below is the list of 5 pharmaceutical stocks to buy according to Efrem Kamen’s Pura Vida Investments hedge fund. For a detailed discussion about Efrem Kamen’s investment philosophy and portfolio management strategies please see 10 Pharmaceutical Stocks to Buy According to Efrem Kamen’s Pura Vida Investments.

5. Inspire Medical Systems, Inc. (NYSE:INSP)

Number of Hedge Fund Holders: 29

Efrem Kamen’s Pura Vida Investments has been holding a position in Inspire Medical Systems, Inc. (NYSE:INSP) since the second quarter of 2018. The firm benefited from its long-running position in a medical technology company. The share price of Inspire Medical Systems has soared from its IPO price of $24 in early 2018 to around $220 at present. The share price performance is backed by robust financial growth. The company’s third-quarter revenue of $61.69 million grew 72% year over year and topped the consensus estimate by $6.24 million. 

Of the 867 elite funds tracked by Insider Monkey, 29 were bullish about the company. Like Efrem Kamen’s Pura Vida Investments, D E Shaw and Marshall Wace LLP are among the leading stakeholder in the company. 

Page 1 of 5